Molecular Imaging Program, National Cancer Institute, 10 Center Drive, Room B3B85, Bethesda 20892, MD.
Molecular Imaging Program, National Cancer Institute, 10 Center Drive, Room B3B85, Bethesda 20892, MD; Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD.
Acad Radiol. 2021 May;28(5):664-670. doi: 10.1016/j.acra.2020.03.017. Epub 2020 Apr 16.
The aim of this study was to perform a quantitative assessment of the prostate anatomy with a focus on the relation of prostatic urethral anatomic variation to urinary symptoms.
This retrospective study involved patients undergoing magnetic resonance imaging for prostate cancer who were also assessed for lower urinary tract symptoms. Volumetric segmentations were utilized to derive the in vivo prostatic urethral length and urethral trajectory in coronal and sagittal planes using a piece-wise cubic spline function to derive the angle of the urethra within the prostate. Association of anatomical factors with urinary symptoms was evaluated using ordinal univariable and multivariable logistic regression with IPSS score cutoffs of ≤7, 8-19, and >20 to define mild, moderate, and severe symptoms, respectively.
A total of 423 patients were included. On univariable analysis, whole prostate volume, transition zone volume, prostatic urethral length, urethral angle, and retrourethral volume were all significantly associated with worse urinary symptoms. On multivariable analysis prostatic urethral length was associated with urinary symptoms with a normalized odds ratio of 1.5 (95% confidence interval 1.0-2.2, p = 0.04). In a subset analysis of patients on alpha blockers, maximal urethral angle, transition zone volume as well as urethral length were all associated with worse urinary symptoms.
Multiple parameters were associated with worse urinary symptoms on univariable analysis, but only prostatic urethral length was associated with worse urinary symptoms on multivariable analysis. This study demonstrates the ability of quantitative assessment of prostatic urethral anatomy to predict lower urinary tract symptoms.
本研究旨在对前列腺解剖结构进行定量评估,重点关注前列腺尿道解剖结构的变化与下尿路症状的关系。
本回顾性研究纳入了因前列腺癌接受磁共振成像检查的患者,并对其下尿路症状进行了评估。利用容积分段,采用分段三次样条函数在冠状面和矢状面得出活体前列腺尿道长度和尿道轨迹,得出前列腺内尿道的角度。采用有序单变量和多变量逻辑回归,以 IPSS 评分≤7、8-19 和>20 为界分别定义轻度、中度和重度症状,评估解剖因素与尿症状的相关性。
共纳入 423 例患者。单变量分析显示,整个前列腺体积、移行区体积、前列腺尿道长度、尿道角度和后尿道体积均与更严重的尿症状显著相关。多变量分析显示,前列腺尿道长度与尿症状相关,标准化优势比为 1.5(95%置信区间 1.0-2.2,p=0.04)。在接受 α 受体阻滞剂治疗的患者亚组分析中,最大尿道角度、移行区体积以及尿道长度均与更严重的尿症状相关。
单变量分析显示多个参数与尿症状相关,但多变量分析仅显示前列腺尿道长度与尿症状相关。本研究表明定量评估前列腺尿道解剖结构能够预测下尿路症状。